Robert, N. J., Conkling, P. R., Kuefler, P. R., McIntyre, K. J., Zhan, F., Asmar, L., … O’Shaughnessy, J. (2008). Results of a phase II study of pemetrexed as first-line chemotherapy for advanced or metastatic breast cancer. In Journal of Clinical Oncology (Vol. 26, pp. 1073–1073). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2008.26.15_suppl.1073

Robert, N. J., P. R. Conkling, P. R. Kuefler, K. J. McIntyre, F. Zhan, L. Asmar, Y. Wang, O. O. Shonukan, and J. O’Shaughnessy. “Results of a phase II study of pemetrexed as first-line chemotherapy for advanced or metastatic breast cancer.” In Journal of Clinical Oncology, 26:1073–1073. American Society of Clinical Oncology (ASCO), 2008. https://doi.org/10.1200/jco.2008.26.15_suppl.1073.

Robert NJ, Conkling PR, Kuefler PR, McIntyre KJ, Zhan F, Asmar L, et al. Results of a phase II study of pemetrexed as first-line chemotherapy for advanced or metastatic breast cancer. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2008. p. 1073–1073.

Robert, N. J., et al. “Results of a phase II study of pemetrexed as first-line chemotherapy for advanced or metastatic breast cancer.” Journal of Clinical Oncology, vol. 26, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2008, pp. 1073–1073. Crossref, doi:10.1200/jco.2008.26.15_suppl.1073.

Robert NJ, Conkling PR, Kuefler PR, McIntyre KJ, Zhan F, Asmar L, Wang Y, Shonukan OO, O’Shaughnessy J. Results of a phase II study of pemetrexed as first-line chemotherapy for advanced or metastatic breast cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2008. p. 1073–1073.